MARKETS
Company

KKR’s $5.9 Billion Integer Deal Helps Healthcare Dominate Private Equity in August

Sep 8, 2026 · 03:15 PM ET· updated 1h ago
KKR’s $5.9 Billion Integer Deal Helps Healthcare Dominate Private Equity in August

Global private equity dealmaking fell sharply in August, however, healthcare emerged as the standout, helped by KKR's acquisition of Integer.

Share
Why It Matters

KKR, a big investment company, spent $5.9 billion to buy a healthcare company called Integer. Even though most deal-making slowed down, healthcare deals stayed strong, which shows people still think healthcare businesses are worth betting on.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.